Emily Pickett was just sitting down at home to a fast-food burger — a quick dinner after a full day at her job as a tax consultant. Then the call came.
Ahamed Idris, M.D., was a young researcher studying cardiac arrest and ventilation in 1986 when he witnessed firsthand the lifesaving capability of cardiopulmonary resuscitation, known as CPR.
Four cancer patients experienced a thrilling ride of a lifetime last year – a ride with a purpose to further research into how zero-gravity conditions in space affect the health of astronauts.
UT Southwestern Medical Center researchers have designed and built a microscope capable of creating high-resolution, 3-D images of living cancer cells in realistic, controllable microenvironments.
Using novel gene-editing techniques, researchers in UT Southwestern’s Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center aim to one day find a cure for a devastating muscle disease that weakens the muscles and often leads to premature death.
With some of the best scientists and specialists in the nation, UT Southwestern’s Peter O’Donnell Jr. Brain Institute is poised to make lifesaving medical and scientific advances to help those affected by brain disorders.
The hundreds of nurses who support UT Southwestern’s hospitals and clinics as front-line providers and stewards of exceptional patient care celebrated a significant milestone last year with the Medical Center’s achievement of Magnet designation, recognized as the gold standard of nursing excellence.
Southwestern Health Resources – the clinically integrated health care network formed by UT Southwestern and Texas Health Resources in December 2015 – continued to develop and grow in 2016 with the announcement of its executive leadership and expansion of its affiliated physicians network.
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
UT Southwestern Medical Center researchers have discovered a mutation that causes a rare systemic disorder known as X-linked reticulate pigmentary disorder (XLPDR) and, significantly, the unexpected cellular mechanism by which the mutation causes the disease.